Come up with a name for your new list and we'll add to it:
GigaGen raised a round of funding on August 20, 2012. Investors include
National Science Foundation.
GigaGen is a pre-clinical biotherapeutics company based in the San Francisco Bay Area. The company's science captures the genetic make-up of the entire human immune repertoire, characterizing B and T …